Cargando…

795 Autologous skin cell suspension application for toxic epidermal necrolysis: a case report

INTRODUCTION: Toxic epidermal necrolysis (TEN) is a drug-mediated disease which occurs at the same level of a partial thickness thermal injury. It has been treated with frequent dressing changes and supportive care as there are no definitive therapies. The pathophysiology involves necrosis of kerati...

Descripción completa

Detalles Bibliográficos
Autores principales: Pang, Alan, Pham, Theophilus, Felan, Sarah, Raghuram, Akshay, Terry, Michelle, Bharadia, Deepak, Griswold, John A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945843/
http://dx.doi.org/10.1093/jbcr/irac012.345
_version_ 1784674050696544256
author Pang, Alan
Pham, Theophilus
Felan, Sarah
Raghuram, Akshay
Terry, Michelle
Bharadia, Deepak
Griswold, John A
author_facet Pang, Alan
Pham, Theophilus
Felan, Sarah
Raghuram, Akshay
Terry, Michelle
Bharadia, Deepak
Griswold, John A
author_sort Pang, Alan
collection PubMed
description INTRODUCTION: Toxic epidermal necrolysis (TEN) is a drug-mediated disease which occurs at the same level of a partial thickness thermal injury. It has been treated with frequent dressing changes and supportive care as there are no definitive therapies. The pathophysiology involves necrosis of keratinocytes at the dermal-epidermal junction leading to sloughing of the epidermis and sub-epidermal bullae. Patients have massive fluid and electrolyte dysregulation due to chronic wounds that are susceptible to infection. This case report describes the application of autologous skin cell suspension (ASCS) to a patient with TEN. His hospital course included arrest of the disease process, timely closure of the wound, and minimal wound care. To our knowledge, this is the first case of TEN treated with ASCS. METHODS: The patient was mechanically debrided with a water scalpel hydrosurgery system to remove all devitalized tissue. A donor graft for ASCS was then obtained at standard depth from unaffected skin at the ankle and was processed in the standard fashion and applied to the wound. Clear plastic dressing with a non-adherent, antibiotic impregnated cloth dressing followed by dry non-shear dressing were then applied to the torso. Extremities were dressed in clear plastic dressing, antibiotic impregnated cloth dressing, zinc paste impregnated cloth, dry gauze roll, and elastic compression bandage. This was performed over the patient’s anterior surface and subsequently on the posterior one week later. Dressings were taken down on post-operative day (POD) 6 and replaced as appropriate. RESULTS: The patient demonstrated 60% closure of wounds on his anterior torso at POD 6. By POD 8, the patient's anterior torso and face were completely closed. His second application of ASCS to his posterior closed in a similar timeline. The patient was discharged on POD 16 from his initial intervention with 2% total body surface area open. At POD 30, his wounds were healed with the return of a large portion of pigmentation. CONCLUSIONS: TEN is a rare, high-mortality disease without efficacious therapy. Given that the wounds are at a similar level to a partial thickness burn, ASCS could be a new intervention which could mitigate open wounds, frequent dressing changes, prolonged hospital stays, and mortality.
format Online
Article
Text
id pubmed-8945843
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-89458432022-03-28 795 Autologous skin cell suspension application for toxic epidermal necrolysis: a case report Pang, Alan Pham, Theophilus Felan, Sarah Raghuram, Akshay Terry, Michelle Bharadia, Deepak Griswold, John A J Burn Care Res Surgical Care, Acute Non-reconstructive 2 INTRODUCTION: Toxic epidermal necrolysis (TEN) is a drug-mediated disease which occurs at the same level of a partial thickness thermal injury. It has been treated with frequent dressing changes and supportive care as there are no definitive therapies. The pathophysiology involves necrosis of keratinocytes at the dermal-epidermal junction leading to sloughing of the epidermis and sub-epidermal bullae. Patients have massive fluid and electrolyte dysregulation due to chronic wounds that are susceptible to infection. This case report describes the application of autologous skin cell suspension (ASCS) to a patient with TEN. His hospital course included arrest of the disease process, timely closure of the wound, and minimal wound care. To our knowledge, this is the first case of TEN treated with ASCS. METHODS: The patient was mechanically debrided with a water scalpel hydrosurgery system to remove all devitalized tissue. A donor graft for ASCS was then obtained at standard depth from unaffected skin at the ankle and was processed in the standard fashion and applied to the wound. Clear plastic dressing with a non-adherent, antibiotic impregnated cloth dressing followed by dry non-shear dressing were then applied to the torso. Extremities were dressed in clear plastic dressing, antibiotic impregnated cloth dressing, zinc paste impregnated cloth, dry gauze roll, and elastic compression bandage. This was performed over the patient’s anterior surface and subsequently on the posterior one week later. Dressings were taken down on post-operative day (POD) 6 and replaced as appropriate. RESULTS: The patient demonstrated 60% closure of wounds on his anterior torso at POD 6. By POD 8, the patient's anterior torso and face were completely closed. His second application of ASCS to his posterior closed in a similar timeline. The patient was discharged on POD 16 from his initial intervention with 2% total body surface area open. At POD 30, his wounds were healed with the return of a large portion of pigmentation. CONCLUSIONS: TEN is a rare, high-mortality disease without efficacious therapy. Given that the wounds are at a similar level to a partial thickness burn, ASCS could be a new intervention which could mitigate open wounds, frequent dressing changes, prolonged hospital stays, and mortality. Oxford University Press 2022-03-23 /pmc/articles/PMC8945843/ http://dx.doi.org/10.1093/jbcr/irac012.345 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the American Burn Association. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Surgical Care, Acute Non-reconstructive 2
Pang, Alan
Pham, Theophilus
Felan, Sarah
Raghuram, Akshay
Terry, Michelle
Bharadia, Deepak
Griswold, John A
795 Autologous skin cell suspension application for toxic epidermal necrolysis: a case report
title 795 Autologous skin cell suspension application for toxic epidermal necrolysis: a case report
title_full 795 Autologous skin cell suspension application for toxic epidermal necrolysis: a case report
title_fullStr 795 Autologous skin cell suspension application for toxic epidermal necrolysis: a case report
title_full_unstemmed 795 Autologous skin cell suspension application for toxic epidermal necrolysis: a case report
title_short 795 Autologous skin cell suspension application for toxic epidermal necrolysis: a case report
title_sort 795 autologous skin cell suspension application for toxic epidermal necrolysis: a case report
topic Surgical Care, Acute Non-reconstructive 2
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945843/
http://dx.doi.org/10.1093/jbcr/irac012.345
work_keys_str_mv AT pangalan 795autologousskincellsuspensionapplicationfortoxicepidermalnecrolysisacasereport
AT phamtheophilus 795autologousskincellsuspensionapplicationfortoxicepidermalnecrolysisacasereport
AT felansarah 795autologousskincellsuspensionapplicationfortoxicepidermalnecrolysisacasereport
AT raghuramakshay 795autologousskincellsuspensionapplicationfortoxicepidermalnecrolysisacasereport
AT terrymichelle 795autologousskincellsuspensionapplicationfortoxicepidermalnecrolysisacasereport
AT bharadiadeepak 795autologousskincellsuspensionapplicationfortoxicepidermalnecrolysisacasereport
AT griswoldjohna 795autologousskincellsuspensionapplicationfortoxicepidermalnecrolysisacasereport